Page last updated: 2024-08-17

dehydroepiandrosterone and roflumilast

dehydroepiandrosterone has been researched along with roflumilast in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dong, X; Ji, X; Liu, S; Wang, L; Ye, Y	1

Other Studies

1 other study(ies) available for dehydroepiandrosterone and roflumilast

Article	Year
PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro. Drug development research, 2023, Volume: 84, Issue:2 Topics: Animals; Apoptosis; Dehydroepiandrosterone; Female; Granulosa Cells; Humans; Inflammation; Lipids; Mice; Phosphodiesterase 4 Inhibitors; Polycystic Ovary Syndrome; Progesterone; Testosterone	2023

Article

Year

PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro.

Drug development research, 2023, Volume: 84, Issue:2

Topics: Animals; Apoptosis; Dehydroepiandrosterone; Female; Granulosa Cells; Humans; Inflammation; Lipids; Mice; Phosphodiesterase 4 Inhibitors; Polycystic Ovary Syndrome; Progesterone; Testosterone

2023